October 3, 2018 / 6:20 AM / 21 days ago

BRIEF-Boston Pharmaceuticals says licenses five programmes from GSK

Oct 3 (Reuters) - GlaxoSmithKline PLC:

* BOSTON PHARMACEUTICALS SAYS HAS IN-LICENSED A PORTFOLIO OF FIVE EARLY DEVELOPMENT PROGRAMMES FROM GLAXOSMITHKLINE

* BOSTON PHARMACEUTICALS SAYS PORTFOLIO INCLUDES TWO PHASE 2-READY DEVELOPMENT CANDIDATES, ONE PHASE 1-READY DEVELOPMENT CANDIDATE AND TWO UNDISCLOSED PRECLINICAL PROGRAMMES WITH IDENTIFIED LEAD CANDIDATES

* BOSTON PHARMACEUTICALS SAYS FINANCIAL TERMS OF THE TRANSACTION WERE NOT DISCLOSED Further company coverage: (Reporting By Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below